REPLIMUNE GROUP INC (REPL) Fundamental Analysis & Valuation

NASDAQ:REPL • US76029N1063

7.15 USD
-0.43 (-5.67%)
Last: Mar 13, 2026, 01:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This REPL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall REPL gets a fundamental rating of 2 out of 10. We evaluated REPL against 519 industry peers in the Biotechnology industry. Both the profitability and financial health of REPL have multiple concerns. REPL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. REPL Profitability Analysis

1.1 Basic Checks

  • In the past year REPL has reported negative net income.
  • REPL had a negative operating cash flow in the past year.
  • In the past 5 years REPL always reported negative net income.
  • REPL had a negative operating cash flow in each of the past 5 years.
REPL Yearly Net Income VS EBIT VS OCF VS FCFREPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

  • REPL's Return On Assets of -94.38% is on the low side compared to the rest of the industry. REPL is outperformed by 74.18% of its industry peers.
  • The Return On Equity of REPL (-149.55%) is worse than 63.01% of its industry peers.
Industry RankSector Rank
ROA -94.38%
ROE -149.55%
ROIC N/A
ROA(3y)-38.68%
ROA(5y)-31.31%
ROE(3y)-49.49%
ROE(5y)-38.68%
ROIC(3y)N/A
ROIC(5y)N/A
REPL Yearly ROA, ROE, ROICREPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • REPL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REPL Yearly Profit, Operating, Gross MarginsREPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. REPL Health Analysis

2.1 Basic Checks

  • REPL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for REPL has been increased compared to 5 years ago.
  • Compared to 1 year ago, REPL has an improved debt to assets ratio.
REPL Yearly Shares OutstandingREPL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
REPL Yearly Total Debt VS Total AssetsREPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • REPL has an Altman-Z score of -4.34. This is a bad value and indicates that REPL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -4.34, REPL is doing worse than 60.50% of the companies in the same industry.
  • A Debt/Equity ratio of 0.33 indicates that REPL is not too dependend on debt financing.
  • REPL's Debt to Equity ratio of 0.33 is on the low side compared to the rest of the industry. REPL is outperformed by 67.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -4.34
ROIC/WACCN/A
WACCN/A
REPL Yearly LT Debt VS Equity VS FCFREPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 5.60 indicates that REPL has no problem at all paying its short term obligations.
  • REPL has a Current ratio (5.60) which is comparable to the rest of the industry.
  • A Quick Ratio of 5.60 indicates that REPL has no problem at all paying its short term obligations.
  • REPL has a Quick ratio of 5.60. This is in the better half of the industry: REPL outperforms 61.08% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 5.6
REPL Yearly Current Assets VS Current LiabilitesREPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. REPL Growth Analysis

3.1 Past

  • REPL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.05%.
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • REPL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.04% yearly.
  • The Revenue is expected to grow by 175.20% on average over the next years. This is a very strong growth
EPS Next Y-13.46%
EPS Next 2Y11.58%
EPS Next 3Y15.13%
EPS Next 5Y17.04%
Revenue Next Year-100%
Revenue Next 2Y431.91%
Revenue Next 3Y329.96%
Revenue Next 5Y175.2%

3.3 Evolution

REPL Yearly Revenue VS EstimatesREPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2025 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
REPL Yearly EPS VS EstimatesREPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. REPL Valuation Analysis

4.1 Price/Earnings Ratio

  • REPL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REPL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REPL Price Earnings VS Forward Price EarningsREPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REPL Per share dataREPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

  • REPL's earnings are expected to grow with 15.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.58%
EPS Next 3Y15.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. REPL Dividend Analysis

5.1 Amount

  • REPL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REPL Fundamentals: All Metrics, Ratios and Statistics

REPLIMUNE GROUP INC

NASDAQ:REPL (3/13/2026, 1:44:08 PM)

7.15

-0.43 (-5.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-03
Earnings (Next)05-20
Inst Owners97.48%
Inst Owner Change-0.28%
Ins Owners2.28%
Ins Owner Change1.43%
Market Cap590.38M
Revenue(TTM)N/A
Net Income(TTM)-314.85M
Analysts82.86
Price Target13.11 (83.36%)
Short Float %19.44%
Short Ratio11.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.43%
Min EPS beat(2)-12.32%
Max EPS beat(2)15.18%
EPS beat(4)1
Avg EPS beat(4)-4.83%
Min EPS beat(4)-15.38%
Max EPS beat(4)15.18%
EPS beat(8)3
Avg EPS beat(8)-1.57%
EPS beat(12)5
Avg EPS beat(12)0.68%
EPS beat(16)7
Avg EPS beat(16)-0.01%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.27%
PT rev (3m)2.27%
EPS NQ rev (1m)14.41%
EPS NQ rev (3m)14.41%
EPS NY rev (1m)4.87%
EPS NY rev (3m)4.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.8
P/tB 2.8
EV/EBITDA N/A
EPS(TTM)-3.44
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-3.42
FCFYN/A
OCF(TTM)-3.36
OCFYN/A
SpS0
BVpS2.55
TBVpS2.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -94.38%
ROE -149.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.68%
ROA(5y)-31.31%
ROE(3y)-49.49%
ROE(5y)-38.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 156.81%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 5.6
Altman-Z -4.34
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)165.62%
Cap/Depr(5y)149.09%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.53%
EPS Next Y-13.46%
EPS Next 2Y11.58%
EPS Next 3Y15.13%
EPS Next 5Y17.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y431.91%
Revenue Next 3Y329.96%
Revenue Next 5Y175.2%
EBIT growth 1Y-35.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A

REPLIMUNE GROUP INC / REPL FAQ

What is the fundamental rating for REPL stock?

ChartMill assigns a fundamental rating of 2 / 10 to REPL.


What is the valuation status of REPLIMUNE GROUP INC (REPL) stock?

ChartMill assigns a valuation rating of 0 / 10 to REPLIMUNE GROUP INC (REPL). This can be considered as Overvalued.


What is the profitability of REPL stock?

REPLIMUNE GROUP INC (REPL) has a profitability rating of 0 / 10.


Can you provide the financial health for REPL stock?

The financial health rating of REPLIMUNE GROUP INC (REPL) is 3 / 10.